Medtronic (NYSE: MDT) announced today that it entered into a definitive agreement to acquire Scientia Vascular in a deal valued at $550 million. Salt Lake City, Utah-based Scientia Vascular develops access products for treating complex neurovascular conditions. Its portfolio features guidewires and catheters that Medtronic can seamlessly … [Read more...] about Medtronic makes neurovascular play with $550M Scientia Vascular buy
Mergers & Acquisitions
Boston Scientific to acquire Penumbra for $14.5B
Boston Scientific (NYSE: BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker Penumbra (NYSE:PEN). The deal values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. Penumbra shares currently trade at approximately $313.43 apiece ahead of the market opening … [Read more...] about Boston Scientific to acquire Penumbra for $14.5B
Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical. Galway, Ireland-based Vivasure develops the PerQSeal Elite system, the first sutureless, fully absorbable synthetic implant for large-bore vessel punctures. Placement occurs from inside the vessel. It makes deployment simpler and … [Read more...] about Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
W.L. Gore to acquire left atrial appendage device maker Conformal Medical
W.L. Gore & Associates announced today that it agreed to acquire left atrial appendage occlusion (LAAO) device maker Conformal Medical. The companies expect to close their deal early this year, subject to regulatory approval. Financial terms of the deal were not disclosed. Nashua, New Hampshire–based Conformal develops the CLAAS AcuForm … [Read more...] about W.L. Gore to acquire left atrial appendage device maker Conformal Medical
Merit Medical to acquire cryoballoon tech from Pentax
Merit Medical Systems (Nasdaq:MMSI) announced an agreement to acquire the C2 CryoBalloon device from a Pentax Medical subsidiary. South Jordan, Utah-based Merit signed a definitive asset purchase agreement with Pentax of America over the C2 CryoBalloon and related technology. The companies expect the closing of the deal to occur during the fourth … [Read more...] about Merit Medical to acquire cryoballoon tech from Pentax
Acutus to sell electrophysiology assets to EnChannel
EnChannel Medical announced today that it agreed to acquire the AcQMap platform assets from Acutus Medical. This deal centers around the AcQMap high-resolution imaging and mapping platform from Acutus. It also includes substantive intellectual property, quality and regulatory documentation and clinical data. With the agreement, EnChannel receives … [Read more...] about Acutus to sell electrophysiology assets to EnChannel
Teleflex completes acquisition of Biotronik’s Vascular Intervention business
Teleflex [WtwhTicker symbol="TFX"](NYSE: TFX)[/WtwhTicker] announced today that it completed its previously announced acquisition of the Biotronik Vascular Intervention (VI) business. As part of strategy shifts by both companies, Teleflex in February agreed to acquire substantially all of the Biotronik VI unit. The acquisition adds a broad … [Read more...] about Teleflex completes acquisition of Biotronik’s Vascular Intervention business
Boston Scientific completes SoniVie acquisition
Boston Scientific announced today that it completed its previously announced acquisition of SoniVie. In March, Boston Scientific announced that it agreed to acquire the intravascular ultrasound system developer. This acquisition brings Boston Scientific into the now-competitive renal denervation (RDN) space. Recor Medical received a landmark … [Read more...] about Boston Scientific completes SoniVie acquisition
FTC challenges private equity firm’s acquisition of Surmodics
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics by GTCR. According to a news release, GTCR also owns a majority stake in Biocoat. The FTC says Biocoat is the second-largest provider of outsourced hydrophilic medical device coatings, behind only Surmodics. As a result, the FTC … [Read more...] about FTC challenges private equity firm’s acquisition of Surmodics
Boston Scientific to acquire renal denervation company SoniVie
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie. Marlborough, Massachusetts-based Boston Scientific is a strategic investor in SoniVie, holding about a 10% equity stake. With this stake, the transaction features an upfront payment of approximately $360 million for the 90% … [Read more...] about Boston Scientific to acquire renal denervation company SoniVie
